Core Viewpoint - The company has approved a plan for a non-public bond issuance aimed at professional investors, with a total scale not exceeding RMB 220 million, to be used for repaying debts and other legal purposes [1][2][3] Group 1: Bond Issuance Details - The bond will have a face value of RMB 100 per unit and can be issued in one or multiple phases [2] - The bond's term will not exceed 7 years, with the specific structure to be determined based on market conditions [2][3] - The funds raised will be used primarily for repaying interest-bearing debts and other purposes allowed by law [2][3] Group 2: Approval and Voting - All 9 attending directors voted in favor of the bond issuance plan, representing 100% of the voting rights [2][3][4] - The resolution for the bond issuance is subject to approval at the company's shareholders' meeting [2][4] Group 3: Management and Authorization - The board has been authorized to handle all matters related to the bond issuance, including regulatory approvals and the finalization of issuance terms [4][5] - The authorization is valid for 24 months from the date of shareholder approval [4] Group 4: Additional Financial Arrangements - The company has increased the borrowing limit from its controlling shareholder from RMB 200 million to RMB 250 million, with a loan term of up to 10 months at an annual interest rate of 6.9% [6][7] - The company will provide a guarantee for its wholly-owned subsidiary's financing lease business, with a limit of RMB 250 million [6][7] Group 5: Upcoming Shareholder Meeting - The company plans to hold its 2024 annual shareholder meeting on June 3, 2025 [7]

亚星化学（600319）公告，公司于2025年5月12日召开董事会，审议通过了非公开发行公司债券的议 案。该债券面值100元/张，总规模不超过人民币2.2亿元(含2.2亿元)，可以一次发行或分期发行。债券期 限为不超过7年期(含7年)，募集资金将用于偿还公司及下属子公司有息负债及法律法规允许的其他用 途。本次债券为固定利率债券，票面利率将根据网下询价簿记结果确定。本次发行方案尚需提交股东大 会审议，并获得上海证券交易所无异议函后方可实施。 ...